Clinical Trial

V+PSF-M for Tobacco Cessation in HIV Care in India

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated June 15, 2025 (before its estimated July 22, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this research study is to test an intervention to help quit tobacco use in participants with Human Immunodeficiency Virus (HIV). The study interventions used in this research study are: * Positively Smoke Free - Mobile (PSF-M) (mobile behavioral program) * Varenicline (or Chantix, apovarenicline, Champix or Nocrav)
Protocol Amendment History 12 amendments
This ClinicalTrials.gov record has been amended 12 times since 2023-03-13; most recent amendment 2025-06-13.
Status change: Not Yet Recruiting → Recruiting 2024-01-12
Trial Details
NCT Number NCT05786547
Lead Sponsor University of Colorado, Denver
Collaborators: National Cancer Institute (NCI)
Conditions Human Immunodeficiency Virus, Smoking Cessation, Smoking, Tobacco
Enrollment 400 participants
Start Date 2024-01-02
Primary Completion 2026-07-22 (estimated)
Study Completion 2026-07-22 (estimated)
Updated on ClinicalTrials.gov 2025-06-15